Kobo Biotech (BSE 531541)₹3.56−1.93%Commodity Chemicals
Kobo Biotech is compared with the 10 closest in size in Commodity Chemicals (80 companies in the industry). It has a ROCE of −125.5% against a peer median of 2.1%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Commodity Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TECIL Chemicals and Hydro Power | 16 | — | — | — | — | 0.0 | 0 | −0 | — | — | vs BSE 531541 |
| Square Four Projects India | 15 | — | −1.2 | −1.5 | 0.09 | 0.0 | 0 | −0 | — | — | vs BSE 531541 |
| Emmessar Biotech & Nutrition | 12 | 29.2 | 7.3 | 5.6 | 0.00 | 0.0 | 0 | 0 | −30.0 | −22.2 | vs BSE 531541 |
| Link Pharma Chem | 11 | — | 3.5 | 0.6 | 0.57 | 0.0 | 27 | 0 | 12.4 | −19.5 | vs BSE 531541 |
| Lime Chemicals | 10 | — | −2.0 | −9.2 | 2.65 | 0.0 | 7 | −0 | 38.8 | −42.9 | vs BSE 531541 |
| Kuwer Industries | 9 | 5.3 | 8.9 | 10.5 | 1.81 | 0.0 | 73 | 2 | 118.9 | — | vs BSE 531541 |
| Sreechem Resins | 9 | — | −0.6 | −1.6 | 0.20 | 0.0 | 30 | −0 | −11.2 | 92.7 | vs BSE 531541 |
| Kobo Biotech | 8 | — | −125.5 | — | — | 0.0 | 0 | −5 | — | — | — |
| Bhagawati Oxygen | 8 | 2.6 | 49.0 | 58.3 | 0.15 | 0.0 | 0 | 3 | — | 2,400.0 | vs BSE 531541 |
| Omkar Pharmachem | 6 | 33.5 | 0.7 | 0.5 | 0.00 | 0.0 | 0 | 0 | −33.3 | — | vs BSE 531541 |
| Padmanabh Industries | 5 | 20.4 | 17.5 | 343.0 | 6.15 | 0.0 | 22 | 0 | 890.9 | — | vs BSE 531541 |
| Peer median | 9 | 20.4 | 2.1 | 0.6 | 0.20 | 0.0 | 0 | 0 | 12.4 | −19.5 |
Listed companies closest to Kobo Biotech in Commodity Chemicals include TECIL Chemicals and Hydro Power, Square Four Projects India, Emmessar Biotech & Nutrition, Link Pharma Chem, Lime Chemicals, Kuwer Industries, Sreechem Resins, Bhagawati Oxygen.
TECIL Chemicals and Hydro Power, with a market cap of ₹16.30 Cr.
Kobo Biotech's return on capital employed is −125.5%, below the peer median of 2.1%.